Prolonged‐release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Summary: Melatonin, secreted nocturnally by the pineal gland, is an endogenous sleep regulator. Impaired melatonin production and complaints on poor quality of sleep are common among the elderly. Non‐restorative sleep (perceived poor quality of sleep) and subsequently poor daytime functioning are increasingly recognized as a leading syndrome in the diagnostic and therapeutic process of insomnia complaints. The effects of 3‐weeks prolonged‐release melatonin 2 mg (PR‐melatonin) versus placebo treatment were assessed in a multi‐center randomized placebo‐controlled study in 170 primary insomnia outpatients aged ≥55 years. Improvements in quality of sleep (QOS) the night before and morning alertness (BFW) were assessed using the Leeds Sleep Evaluation Questionnaire and changes in sleep quality (QON) reported on five categorical unit scales. Rebound insomnia and withdrawal effects following discontinuation were also evaluated. PR‐melatonin significantly improved QOS (−22.5 versus −16.5 mm, P = 0.047), QON (0.89 versus 0.46 units; P = 0.003) and BFW (−15.7 versus −6.8 mm; P = 0.002) compared with placebo. The improvements in QOS and BFW were strongly correlated (Rval = 0.77, P < 0.001) suggesting a beneficial treatment effect on the restorative value of sleep. These results were confirmed in a subgroup of patients with a greater symptom severity. There was no evidence of rebound insomnia or withdrawal effects following treatment discontinuation. The incidence of adverse events was low and most side‐effects were judged to be of minor severity. PR‐melatonin is the first drug shown to significantly improve quality of sleep and morning alertness in primary insomnia patients aged 55 years and older‐suggesting more restorative sleep, and without withdrawal symptoms upon discontinuation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 5×
“According to a recent meta-analysis the efficacy of the major hypnotic drugs in improving sleep quality in the elderly population is much lower, with an NNT value of 13 (Glass et al., 2005).”
BackgroundMethodInfluentialThe melatonin rhythm: both a clock and a calendar
Reiter, R. J. (1993) · Experientia · doi:10.1007/bf01923947 · Cited by 995
Improvement of sleep quality in elderly people by controlled-release melatonin
Garfinkel, D., Laudon, M., Nof, D., & Zisapel, N. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91382-3 · Cited by 474
Self-citationQuality of life in people with insomnia.
Zammit, G. K., Weiner, J., Damato, N., Sillup, G. P., & McMillan, C. A. (1999) · PubMed · Cited by 467
Evaluation of Chronic Insomnia
Sateia, M. J., Doghramji, K., Hauri, P. J., & Morin, C. M. (2000) · Sleep · doi:10.1093/sleep/23.2.1l · Cited by 466
Epidemiological Study on Insomnia in the General Population
Ohayon, M. (1996) · Sleep · doi:10.1093/sleep/19.suppl_3.s7 · Cited by 401
Melatonin Replacement Therapy of Elderly Insomniacs
Haimov, I., Lavie, P., Laudon, M., Herer, P., Vigder, C., & Zisapel, N. (1995) · Sleep · doi:10.1093/sleep/18.7.598 · Cited by 344
Self-citationARENDT, J., BOJKOWSKI, C., FRANEY, C., WRIGHT, J., & MARKS, V. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-6-1166 · Cited by 341
Practice Parameters for the Evaluation of Chronic Insomnia
Chesson, A., Hartse, K., Anderson, W. M., Davila, D., Johnson, S., Littner, M., Wise, M., & Rafecas, J. (2000) · Sleep · doi:10.1093/sleep/23.2.1k · Cited by 332
Desforges, J. F., Prinz, P. N., Vitiello, M. V., Raskind, M. A., & Thorpy, M. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230805 · Cited by 318
Sleep disorders and melatonin rhythms in elderly people
Haimov, I., Laudon, M., Zisapel, N., Souroujon, M., Nof, D., Shlitner, A., Herer, P., Tzischinsky, O., & Lavie, P. (1994) · BMJ · doi:10.1136/bmj.309.6948.167 · Cited by 315
Self-citationOn the effect of melatonin upon human brain. Its possible therapeutic implications
Antón-Tay, F., Díaz, J. L., & Fernández-Guardiola, A. (1971) · Life Sciences · doi:10.1016/0024-3205(71)90155-x · Cited by 311
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Melatonin treatment for age-related insomnia
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., & Leclair, O. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7901 · Cited by 308
Practice Parameters for Using Polysomnography to Evaluate Insomnia: An Update
Littner, M., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D., Berry, R. B., Davila, D., Johnson, S., Kushida, C., et al. (2003) · Sleep · doi:10.1093/sleep/26.6.754 · Cited by 306 · cited 1×
“…papers have been issued by several expert groups including a recent report of the American Academy Sleep Medicine Standards of Practice Committee, concluding that polysomnography should not be indicated for the routine evaluation of insomnia (e.g. Costae Silva et al., 1996; Littner et al., 2003).”
BackgroundBioavailability of Oral Melatonin in Humans
Waldhauser, F., Waldhauser, M., Lieberman, H. R., Deng, M.-H., Lynch, H. J., & Wurtman, R. J. (1984) · Neuroendocrinology · doi:10.1159/000123997 · Cited by 304
Melatonin receptors and their regulation: biochemical and structural mechanisms
Witt-Enderby, P. A., Bennett, J., Jarzynka, M. J., Firestine, S., & Melan, M. A. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00098-5 · Cited by 302
Sleep and quality of life in the Austrian population
Zeitlhofer, J., Schmeiser-Rieder, A., Tribl, G., Rosenberger, A., Bolitschek, J., Kapfhammer, G., Saletu, B., Katschnig, H., Holzinger, B., Popovic, R., et al. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102004249.x · Cited by 265
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Roth, T., Seiden, D., Sainati, S., Wang-Weigand, S., Zhang, J., & Zee, P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.01.003 · Cited by 265
Ohayon, M. M., Zulley, J., Guilleminault, C., Smirne, S., & Priest, R. G. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49077.x · Cited by 253
Factor analysis of a sleep evaluation questionnaire
Parrott, A. C., & Hindmarch, I. (1978) · Psychological Medicine · doi:10.1017/s0033291700014379 · Cited by 238
“White Paper” on Sleep and Aging
DEMENT, W. C., MILES, L. E., & CARSKADON, M. A. (1982) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1982.tb03700.x · Cited by 223
Sleep and sleep disturbances: biological basis and clinical implications
Zisapel, N. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6529-9 · Cited by 214
Self-citationAcute Pharmacology of Melatonin
BARCHAS, J., DACOSTA, F., & SPECTOR, S. (1967) · Nature · doi:10.1038/214919a0 · Cited by 209
Epidemiology of severe insomnia and its consequences in Germany
Hajak, G. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170052 · Cited by 202
Chesson, A. L., Hartse, K. M., Anderson, W. M., Davila, D., Johnson, S. F., Littner, M. R., Wise, M. S., & Rafecas, J. (2000) · PubMed · Cited by 193
The benzodiazepine withdrawal symptom questionnaire
Tyrer, P., Murphy, S., & Riley, P. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90009-w · Cited by 188
Sleep EEG Power Spectra, Insomnia, and Chronic Use of Benzodiazepines
Bastien, C. H., LeBlanc, M., Carrier, J., & Morin, C. M. (2003) · Sleep · doi:10.1093/sleep/26.3.313 · Cited by 181
Rosenzweig, P., Canal, M., Patat, A., Bergougnan, L., Zieleniuk, I., & Bianchetti, G. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.320 · Cited by 177
Measuring outcomes in randomized clinical trials of insomnia treatments
Morin, C. M. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0274 · Cited by 172
Correlates of Global Sleep Dissatisfaction in the German Population
(2001) · Sleep · doi:10.1093/sleep/24.7.780 · Cited by 159
Leger, D., Laudon, M., & Zisapel, N. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.017 · Cited by 158
Self-citationAncoli-Israel, S., Walsh, J. K., Mangano, R. M., & Fujimori, M. (1999) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v01n0404 · Cited by 140
Improvement of sleep quality by melatonin
Wurtman, R. J., & Zhdanova, I. V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92509-0 · Cited by 140
Costa E Silva, J. A., Chase, M., Sartorius, N., & Roth, T. (1996) · Sleep · doi:10.1093/sleep/19.5.412 · Cited by 139
Zisapel, N., & Nir, T. (2003) · Journal of Sleep Research · doi:10.1046/j.0962-1105.2003.00365.x · Cited by 138
Self-citationVgontzas, A. N., Bixler, E. O., Wittman, A. M., Zachman, K., Lin, H.-M., Vela-Bueno, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7370 · Cited by 134 · cited 1×
“Elevation of plasma cortisol impairs sleep in middle-aged but not younger adults (Vgontzas et al., 2001).”
BackgroundOn the effects of melatonin on sleep and behavior in man.
Cramer, H., Rudolph, J. L., Consbruch, U., & Kendel, K. (1974) · PubMed · Cited by 114
Melatonin Receptors in Discrete Brain Areas of the Male Rat
Laudon, M., Nir, I., & Zisapel, N. (1988) · Neuroendocrinology · doi:10.1159/000125066 · Cited by 111
Self-citationSleep Disorders and Aging: Understanding the Causes
Vitiello, M. V. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.4.m189 · Cited by 109
Dose response effects of zolpidem in normal geriatric subjects.
Scharf, M. B., Mayleben, D. W., Kaffeman, M., Krall, R. C., & Ochs, R. F. (1991) · PubMed · Cited by 98
Comparability of Sleep Disorders Diagnoses Using DSM-IV and ICSD Classifications with Adolescents
Ohayon, M. M., & Roberts, R. E. (2001) · Sleep · doi:10.1093/sleep/24.8.920 · Cited by 96
Sleep-anticipating effects of melatonin in the human brain
Gorfine, T., Assaf, Y., Goshen‐Gottstein, Y., Yeshurun, Y., & Zisapel, N. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.11.024 · Cited by 90
Self-citationDrugs for sleep disorders: mechanisms and therapeutic prospects
Szabadi, E. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02680.x · Cited by 89
The Dim Light Melatonin Onset, Melatonin Assays and Biological Rhythm Research in Humans
Lewy, A. (1999) · Neurosignals · doi:10.1159/000014573 · Cited by 87
Cross‐cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients
Tarrasch, R., Laudon, M., & Zisapel, N. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.534 · Cited by 85
Self-citationDoes melatonin improve sleep in older people? A randomised crossover trial
Baskett, J. J. (2003) · Age and Ageing · doi:10.1093/ageing/32.2.164 · Cited by 83
Riedel, B. W., & Lichstein, K. L. (1998) · Psychology and Aging · doi:10.1037//0882-7974.13.1.159 · Cited by 82
Treating the Health, Quality of Life, and Functional Impairments in Insomnia
Krystal, A. D. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26749 · Cited by 79
CONSENSUS FOR THE PHARMACOLOGICAL MANAGEMENT OF INSOMNIA IN THE NEW MILLENNIUM
Roth, T., Hajak, G., & Üstün, T. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb10973.x · Cited by 74
Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
Paul, M. A., Gray, G. W., Kenny, G., & Pigeau, R. (2003) · PubMed · Cited by 70
Zisapel, N., & Laudon, M. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.455 · Cited by 68
Self-citationNugent, A. M., Gleadhill, I. C., McCrum, E. E., Patterson, C. C., Evans, A., & MacMahon, J. (2001) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2001.00226.x · Cited by 57
The changing perspective on chronic insomnia management.
Krystal, A. D. (2004) · PubMed · Cited by 55
The relationship between melatonin and cortisol rhythms: clinical implications of melatonin therapy
Zisapel, N., Tarrasch, R., & Laudon, M. (2005) · Drug Development Research · doi:10.1002/ddr.20014 · Cited by 52
Self-citationMelatonin and the human hippocampus, a time dependant interplay
Gorfine, T., & Zisapel, N. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00446.x · Cited by 48
Self-citationMelatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews.
Paul, M. A., Gray, G. W., Sardana, T. M., & Pigeau, R. (2004) · PubMed · Cited by 45
The Use of Melatonin for the Treatment of Insomnia
Zisapel, N. (1999) · Neurosignals · doi:10.1159/000014574 · Cited by 43
Self-citationSearching for New Options for Treating Insomnia: Are Melatonin and Ramelteon Beneficial?
Bellon, A. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200607000-00005 · Cited by 42
Gorfine, T., Yeshurun, Y., & Zisapel, N. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00482.x · Cited by 42
Self-citationDaytime Sleep and Performance Following a Zolpidem and Melatonin Cocktail
Wesensten, N. J., Balkin, T. J., Reichardt, R. M., Kautz, M. A., Saviolakis, G. A., & Belenky, G. L. (2005) · SLEEP · doi:10.1093/sleep/28.1.93 · Cited by 33
Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam.
Paul, M. A., Gray, G. W., MacLellan, M., & Pigeau, R. (2004) · PubMed · Cited by 31
Kieser, M., Röhmel, J., & Friede, T. (2004) · Statistics in Medicine · doi:10.1002/sim.1910 · Cited by 28
Riemann, D. W., FISCHER, J. H., Mayer, G., & Peter, H. J. (2003) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1046/j.1439-054x.2003.03201.x · Cited by 22
Cited by
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
PANDIPERUMAL, S., TRAKHT, I., SRINIVASAN, V, SPENCE, D., MAESTRONI, G., ZISAPEL, N., & CARDINALI, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.001 · Cited by 791
Self-citationWilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063773 · Cited by 483
Metadata
- Authors
- LEMOINE, P., NIR, T., LAUDON, M., & ZISAPEL, N.
- Venue
- Journal of Sleep Research
- Publisher
- Wiley
- Published
- 2007-11-21
- Volume
- 16
- Issue
- 4
- Pages
- 372-380
- ISSN
- 0962-1105 (ISSN-L)
- 1365-2869
- OpenAlex
- W2119800398
- Cited by
- 261
- References
- 65
- FWCI
- 20.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.